Download FREE Report Sample
Download Free sampleAlbumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
Albumin Market contains market size and forecasts of Albumin (as Excipient) in global, including the following market information:
Global Albumin (as Excipient) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Albumin (as Excipient) Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Albumin (as Excipient) companies in 2021 (%)
The global Albumin (as Excipient) market was valued at 4466.1 million in 2021 and is projected to reach US$ 6643.7 million by 2028, at a CAGR of 5.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Human Serum Albumin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Albumin (as Excipient) include CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion and LFB Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Albumin (as Excipient) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Albumin (as Excipient) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Albumin (as Excipient) Market Segment Percentages, by Type, 2021 (%)
Human Serum Albumin
Recombinant Albumin
Global Albumin (as Excipient) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Albumin (as Excipient) Market Segment Percentages, by Application, 2021 (%)
Cell Culture Media
Medical Supplements
Therapeutics
Global Albumin (as Excipient) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Albumin (as Excipient) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Albumin (as Excipient) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Albumin (as Excipient) revenues share in global market, 2021 (%)
Key companies Albumin (as Excipient) sales in global market, 2017-2022 (Estimated), (MT)
Key companies Albumin (as Excipient) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
